Physician profile
Gray W Barrow
NPI 1851433460
$1,239.69
in general payments reported to CMS, 2019-2025
22 companies · $30.68 in 2025
The $30.68 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $710 · 2020: $303 · 2021: $196 · 2025: $30.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $163.86 | 2019 | |
| Collegium Pharmaceutical, INC. | $133.42 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $126.00 | 2019-2021 | |
| Amgen INC. | $98.24 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.13 | 2019-2020 | |
| Pfizer INC. | $66.63 | 2019-2021 | |
| Lilly USA, LLC | $61.29 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $60.47 | 2021 | |
| Ibsa Pharma INC. | $57.52 | 2020-2021 | |
| Kaleo, INC. | $57.29 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.91 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $38.28 | 2019 | |
| Eisai INC. | $36.58 | 2020 | |
| Mdd US Operations, LLC | $35.28 | 2019 | |
| Scilex Pharmaceuticals INC. | $31.42 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $30.68 | 2025 | |
| Abbott Laboratories | $27.69 | 2019 | |
| Abbvie INC. | $16.79 | 2021 | |
| Assertio Therapeutics, INC. | $16.08 | 2019 | |
| Boston Scientific Corporation | $15.79 | 2019 | |
| Stimwave Technologies Incorporated | $15.67 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gray Barrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.